Jerome P. Richie

659 total citations
10 papers, 277 citations indexed

About

Jerome P. Richie is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jerome P. Richie has authored 10 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Jerome P. Richie's work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Sexual Differentiation and Disorders (3 papers). Jerome P. Richie is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Sexual Differentiation and Disorders (3 papers). Jerome P. Richie collaborates with scholars based in United States, Canada and Malaysia. Jerome P. Richie's co-authors include Anindya Dutta, Christopher L. Corless, Robert Mashal, Susan C. Lester, Kathleen J. Propert, Andrew A. Renshaw, Kevin R. Loughlin, Anthony V. D’Amico, Michael R. Jiroutek and Daniel Schultz and has published in prestigious journals such as PLoS ONE, Urology and American Journal of Clinical Pathology.

In The Last Decade

Jerome P. Richie

10 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome P. Richie United States 7 156 96 94 52 48 10 277
Charles R. Sikes United States 10 262 1.7× 175 1.8× 122 1.3× 72 1.4× 26 0.5× 12 402
Felix Chun Germany 6 200 1.3× 100 1.0× 98 1.0× 43 0.8× 24 0.5× 15 303
David Hernández‐Barajas Mexico 8 157 1.0× 135 1.4× 140 1.5× 77 1.5× 25 0.5× 26 322
Yusuke Shinchi Japan 10 84 0.5× 141 1.5× 81 0.9× 34 0.7× 24 0.5× 16 269
Lucile Armenoult France 7 208 1.3× 73 0.8× 88 0.9× 83 1.6× 33 0.7× 9 314
Meike Adam Germany 11 292 1.9× 72 0.8× 217 2.3× 127 2.4× 49 1.0× 22 438
Antti Ylipää Finland 7 155 1.0× 63 0.7× 125 1.3× 93 1.8× 19 0.4× 16 304
C. Rimkus Germany 5 66 0.4× 148 1.5× 169 1.8× 55 1.1× 39 0.8× 10 365
Yunyi Kong China 9 207 1.3× 99 1.0× 111 1.2× 86 1.7× 9 0.2× 14 330
Minhua Zhou China 4 112 0.7× 122 1.3× 210 2.2× 72 1.4× 17 0.4× 8 328

Countries citing papers authored by Jerome P. Richie

Since Specialization
Citations

This map shows the geographic impact of Jerome P. Richie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome P. Richie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome P. Richie more than expected).

Fields of papers citing papers by Jerome P. Richie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome P. Richie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome P. Richie. The network helps show where Jerome P. Richie may publish in the future.

Co-authorship network of co-authors of Jerome P. Richie

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome P. Richie. A scholar is included among the top collaborators of Jerome P. Richie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome P. Richie. Jerome P. Richie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liong, Men Long, Chun Ren Lim, Hengxuan Yang, et al.. (2012). Blood-Based Biomarkers of Aggressive Prostate Cancer. PLoS ONE. 7(9). e45802–e45802. 27 indexed citations
2.
Whittington, Richard, Daniel Schultz, B. Silver, et al.. (2000). Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer.. PubMed. 4(3). 171–5;discussion 177. 20 indexed citations
4.
Richie, Jerome P., et al.. (1998). Tumor, nodes, metastasis (TNM) classification of bladder cancer. Urologic Oncology Seminars and Original Investigations. 4(4-5). 90–93. 2 indexed citations
5.
Mashal, Robert, Susan C. Lester, Christopher L. Corless, et al.. (1996). Expression of cell cycle-regulated proteins in prostate cancer.. PubMed. 56(18). 4159–63. 121 indexed citations
6.
Richie, Jerome P.. (1994). MANAGEMENT OF PATIENTS WITH POSITIVE SURGICAL MARGINS FOLLOWING RADICAL PROSTATECTOMY. Urologic Clinics of North America. 21(4). 717–723. 14 indexed citations
7.
Richie, Jerome P.. (1993). Advances in the Diagnosis and Treatment of Testicular Cancer. Cancer Investigation. 11(6). 670–675. 6 indexed citations
9.
Richie, Jerome P.. (1991). Surgical Aspects in the Treatment of Patients with Testicular Cancer. Hematology/Oncology Clinics of North America. 5(6). 1127–1142. 6 indexed citations
10.
Richie, Jerome P.. (1987). Management of Patients With Clinical Stage I or II Nonseminomatous Germ Cell Tumors of the Testis. Archives of Surgery. 122(12). 1443–1443. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026